Related Experiment Videos
REM latency in Alzheimer's disease.
D L Bliwise1, J Tinklenberg, J A Yesavage
1Department of Psychiatry and Behavioral Sciences, Stanford Medical School, CA 94305.
Biological Psychiatry
|February 1, 1989
Summary
Latency to rapid eye movement sleep (REMS) shows potential for Alzheimer's disease (AD) diagnosis. However, this study found REMS latency achieved only 65% accuracy in differentiating AD patients from controls.
Area of Science:
- Neurology
- Sleep Medicine
- Neurodegenerative Diseases
Background:
- Latency to the first episode of rapid eye movement sleep (REMS) is a potential biomarker for Alzheimer's disease (AD).
- Sleep disturbances are common in neurodegenerative conditions.
- Understanding REMS latency may offer insights into AD pathophysiology.
Purpose of the Study:
- To evaluate the diagnostic utility of REMS latency in distinguishing Alzheimer's disease patients from healthy controls.
- To assess the impact of different REMS latency definitions and cutoffs on classification accuracy.
- To explore the relationship between REMS latency and AD-related sleep disturbances.
Main Methods:
- Comparison of REMS latency values between 28 AD patients and 28 age/sex-matched controls.
- Application of multiple definitions and cutoffs for REMS latency.
- Statistical analysis to determine classification accuracy.
Main Results:
- The optimal REMS latency definition and cutoff criterion yielded a classification accuracy of 65% for AD.
- AD patients exhibited longer REMS latency compared to controls.
- This difference may reflect general sleep disruption or specific cholinergic system decline in AD.
Conclusions:
- REMS latency alone has limited accuracy for diagnosing Alzheimer's disease.
- Longer REMS latency in AD patients suggests significant sleep disturbances and potential cholinergic deficits.
- REMS latency may still be valuable in the differential diagnosis of dementia versus pseudodementia, especially when contrasted with other psychiatric disorders.